Tag: NGS

Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. announced a strategic collaboration to increase patient access to...

QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), that brings significant performance...

SOPHiA GENETICS, a cloud-native healthcare technology company and a leader in data-driven medicine, announced that Kepler Uniklinikum, Austria's second largest hospital, is live on...

Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platform, announced a partnership to significantly expand patient...

QIAGEN announced the availability of QCI Secondary Analysis, a cloud-based software-as-a-services (SaaS) solution enabling high-throughput secondary analysis for use with any clinical next-generation sequencing...

Stahl will leverage proven experience in building innovative diagnostic organizations to accelerate InterVenn’s commercialization efforts. InterVenn Biosciences, the life sciences company pioneering glycoproteomic-based diagnostics, announced...